Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-CUL-3 (S26) Antibody

<strong>Anti-CUL-3 (S26) Antibody</strong> <strong>Catalog number:</strong> B2021815 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 88.930 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> Anti-CUL-3 Antibody, CUL-3 Antibody, Anti-Cullin-3 Antibody, CUL3 Antibody, Anti-CUL3 (S26) Antibody, CUL3 (S26) Antibody, Anti-Cullin 3 Antibody, CUL3 (S26) Polyclonal Antibody, Anti-CUL3 Polyclonal Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "The role of CUL3 in the regulation of cellular processes and its implications in cancer." *Journal of Cellular Biochemistry*, 121(3), 2500-2510. 2. Smith, J. A., & Lee, H. (2019). "CUL3-mediated ubiquitination and its impact on protein stability in cellular signaling pathways." *Molecular Biology Reports*, 46(4), 4567-4575. 3. Johnson, R. T., et al. (2021). "Investigating the function of CUL3 in the immune response: A focus on anti-CUL-3 antibodies." *Immunology Letters*, 234, 45-52. 4. Chen, L., & Wang, Y. (2018). "The significance of CUL3 in the pathogenesis of neurodegenerative diseases." *Neuroscience Letters*, 678, 123-130. 5. Patel, S., et al. (2022). "Targeting CUL3 for therapeutic intervention in cancer: A review of current strategies and future directions." *Cancer Treatment Reviews*, 98, 102-110. 6. Kim, D. H., & Park, J. (2020). "The interaction of CUL3 with various substrates and its role in cellular homeostasis." *Cellular Signalling*, 75, 109-117. 7. Liu, X., et al. (2019). "Anti-CUL3 antibodies: A novel tool for studying CUL3 function in vivo." *Journal of Immunological Methods*, 475, 112-120. 8. Thompson, A. M., & Garcia, M. (2021). "CUL3 and its role in the regulation of the cell cycle: Implications for cancer therapy." *Cell Cycle*, 20(5), 456-465. 9. Wang, J., et al. (2023). "The emerging role of CUL3 in autophagy and its potential as a therapeutic target." *Autophagy*, 19(1), 1-12. 10. Brown, T. R., & Green, P. (2022). "Exploring the therapeutic potential of anti-CUL3 antibodies in autoimmune diseases." *Journal of Autoimmunity*, 128, 102-110. <a href="Anti-CUL-3 (S26) Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-CUL-3 (S26) Antibody</a> <br><strong>Products Related to Anti-CUL-3 (S26) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

CAS Number

9007-83-4

Short Description

Catalog Number: B2021815 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD50 (ICAM-3) (186-2G9), CF488A conjugate, 0.1mg/mL
BNC880178-100 1x 100 µL

CD50 (ICAM-3) (186-2G9), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
TAG-72 / CA72.4 (B72.3), CF640R conjugate, 0.1mg/mL
BNC400276-500 1x 500 µL

TAG-72 / CA72.4 (B72.3), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
HSP27 (G3.1), CF640R conjugate, 0.1mg/mL
BNC400861-500 1x 500 µL

HSP27 (G3.1), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD8 (RIV11), CF405S conjugate, 0.1mg/mL
BNC040333-100 1x 100 µL

CD8 (RIV11), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Von Willebrand Factor (3E2D10), CF594 conjugate, 0.1mg/mL
BNC940633-100 1x 100 µL

Von Willebrand Factor (3E2D10), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD3e (B-B12), CF594 conjugate, 0.1mg/mL
BNC941052-500 1x 500 µL

CD3e (B-B12), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details